White House Schedules Cannabis Enforcement Meeting (Newsletter: March 27, 2026)
The federal cannabis enforcement policy is under review following the White House's scheduled meeting in March 2026. This policy directly affects patient access to medical cannabis and clinical practice guidelines. Healthcare providers should stay…
Dan Patrick Adds Data Centers, Prediction Markets and THC to Senate Priorities | State
Texas medical cannabis access barriers are highlighted as THC is added to the Senate's priority agenda. This development may influence patient eligibility and product availability. Clinicians and patients should monitor these evolving policy changes…
FWC Reinstates Employee Amid Workplace Cannabis Testing Policy Debate
Workplace cannabis testing policies are increasingly conflicting with legal medical cannabis use, creating challenges for clinicians and employees. The Fair Work Commission reinstated a 27-year employee fired for a positive drug test, reflecting evolving…
Empire State Weekly: Cannabis Regulator Discusses Product Safety
Cannabis product safety regulation is critical for ensuring quality and consistency in medical cannabis. New York regulators focus on safety standards to protect patients and reduce clinical uncertainty. This evolving oversight supports therapeutic…
Mississippi Gov. Vetoes Medical Marijuana Expansion Bill – Law360 UK
Mississippi medical cannabis bills recently faced a veto by the governor, affecting patient access to regulated cannabis products. This veto limits expansion of the state's medical cannabis program and impacts clinical treatment options. Healthcare…
Dan Patrick Highlights THC in Texas Medical Cannabis Legislative Update
Texas medical cannabis legislative update reveals new priorities including THC access. These developments may signal important policy shifts impacting patient care. Healthcare providers and patients should monitor these changes closely.
Mississippi Governor Vetoes Bills Affecting Medical Cannabis Access
Policy fluctuations medical cannabis access create uncertainty for patients and clinicians alike. Mississippi's recent vetoes highlight challenges in maintaining consistent treatment options. Understanding these changes is crucial for advising patients…
US Congressman Presses DOJ, DEA Heads on Cannabis Rescheduling Timeline
The cannabis rescheduling timeline is critical for advancing federal regulation and medical cannabis research. Congressional pressure on DOJ and DEA heads highlights the urgency of this policy shift. This change could remove barriers to clinical trials…
Governor Vetoes Medical Cannabis Act Over Out-of-State Access
Interstate medical cannabis regulation creates significant barriers for patients who travel or relocate. Residency requirements in state policies often limit access to medical cannabis, affecting treatment continuity. This veto highlights challenges in…
Mississippi Governor Vetoes Medical Cannabis Expansion Bills
Mississippi medical cannabis program challenges continue as the governor vetoes bills expanding access. This policy decision impacts patient care and clinical decision-making. Meanwhile, psychedelic research initiatives advance, creating a complex…